SA515360076B1 - أملاح من مركب البنزوثيازولون الذي يكون مقاوم لمستقبل أدريني بيتا-2 - Google Patents

أملاح من مركب البنزوثيازولون الذي يكون مقاوم لمستقبل أدريني بيتا-2

Info

Publication number
SA515360076B1
SA515360076B1 SA515360076A SA515360076A SA515360076B1 SA 515360076 B1 SA515360076 B1 SA 515360076B1 SA 515360076 A SA515360076 A SA 515360076A SA 515360076 A SA515360076 A SA 515360076A SA 515360076 B1 SA515360076 B1 SA 515360076B1
Authority
SA
Saudi Arabia
Prior art keywords
beta
salts
compound
adrenoceptor agonist
benzothiazolone compound
Prior art date
Application number
SA515360076A
Other languages
English (en)
Inventor
جرانديوري ارنود
توفيلي نيكولا
Original Assignee
نوفارتيس ايه جي
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53386469&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SA515360076(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by نوفارتيس ايه جي filed Critical نوفارتيس ايه جي
Publication of SA515360076B1 publication Critical patent/SA515360076B1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

يقدم الإختراع الحالي المركب بالصيغة (I) على شكل ملح أسيتات acetate salt (I) طريقة لتصنيع المركب الخاص بالإختراع، وإستخداماته العلاجية لعلاج أو الوقاية من تلف العضلات muscular dystrophy، الضمور المتعلق بعدم الإستخدام disuse-related atrophy، دنف cachexia أو ساركوبنيا sarcopenia. ويقدم الإختراع الحالي أيضاً تركيبة من العوامل النشطة دوائياً والتركيبات الصيدلانية.
SA515360076A 2012-08-30 2015-02-26 أملاح من مركب البنزوثيازولون الذي يكون مقاوم لمستقبل أدريني بيتا-2 SA515360076B1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IQ23912 2012-08-30
PCT/IB2013/058109 WO2014033654A1 (en) 2012-08-30 2013-08-29 Salts of benzothiazolone compound as beta-2-adrenoceptor agonist

Publications (1)

Publication Number Publication Date
SA515360076B1 true SA515360076B1 (ar) 2016-03-20

Family

ID=53386469

Family Applications (1)

Application Number Title Priority Date Filing Date
SA515360076A SA515360076B1 (ar) 2012-08-30 2015-02-26 أملاح من مركب البنزوثيازولون الذي يكون مقاوم لمستقبل أدريني بيتا-2

Country Status (27)

Country Link
EP (2) EP3243817A1 (ar)
KR (1) KR20150047586A (ar)
CN (2) CN106146428A (ar)
BR (1) BR112015004127A2 (ar)
CA (1) CA2882877A1 (ar)
CL (1) CL2015000461A1 (ar)
CY (1) CY1120225T1 (ar)
DK (1) DK2890687T3 (ar)
EA (1) EA029946B1 (ar)
ES (1) ES2642003T3 (ar)
HK (1) HK1206015A1 (ar)
HR (1) HRP20171362T1 (ar)
HU (1) HUE033655T2 (ar)
IL (1) IL237382A0 (ar)
LT (1) LT2890687T (ar)
MA (1) MA37872A1 (ar)
MX (1) MX351741B (ar)
MY (1) MY169038A (ar)
NZ (1) NZ705319A (ar)
PE (1) PE20150465A1 (ar)
PL (1) PL2890687T3 (ar)
PT (1) PT2890687T (ar)
SA (1) SA515360076B1 (ar)
SG (2) SG11201501293PA (ar)
SI (1) SI2890687T1 (ar)
TN (1) TN2015000058A1 (ar)
WO (1) WO2014033654A1 (ar)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040962A1 (es) 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
CA2514733A1 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
JP2007537187A (ja) 2004-05-13 2007-12-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療においてβアゴニストとして使用するためのヒドロキシ置換ベンゾ縮合ヘテロ環化合物
GB0426164D0 (en) * 2004-11-29 2004-12-29 Novartis Ag Organic compounds
JO3192B1 (ar) * 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
AU2014222362B2 (en) * 2013-02-28 2016-07-21 Novartis Ag Formulation comprising benzothiazolone compound

Also Published As

Publication number Publication date
LT2890687T (lt) 2017-09-11
NZ705319A (en) 2018-05-25
PT2890687T (pt) 2017-10-05
BR112015004127A2 (pt) 2017-07-04
HRP20171362T1 (hr) 2017-11-03
CN104736525B (zh) 2016-08-24
SG11201501293PA (en) 2015-03-30
MX351741B (es) 2017-10-26
KR20150047586A (ko) 2015-05-04
SI2890687T1 (sl) 2017-10-30
CN104736525A (zh) 2015-06-24
TN2015000058A1 (en) 2016-06-29
PL2890687T3 (pl) 2017-11-30
MY169038A (en) 2019-02-07
EA201590452A1 (ru) 2015-07-30
MX2015002656A (es) 2015-05-20
ES2642003T3 (es) 2017-11-14
EP3243817A1 (en) 2017-11-15
HUE033655T2 (en) 2017-12-28
HK1206015A1 (en) 2015-12-31
EA029946B1 (ru) 2018-06-29
IL237382A0 (en) 2015-04-30
WO2014033654A1 (en) 2014-03-06
SG10201704377PA (en) 2017-06-29
DK2890687T3 (en) 2017-10-09
CL2015000461A1 (es) 2015-05-04
EP2890687B1 (en) 2017-06-28
MA37872A1 (fr) 2018-07-31
CA2882877A1 (en) 2014-03-06
EP2890687A1 (en) 2015-07-08
PE20150465A1 (es) 2015-04-22
CY1120225T1 (el) 2018-12-12
CN106146428A (zh) 2016-11-23

Similar Documents

Publication Publication Date Title
PH12018501807A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseas
PH12016500072B1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
MX2020010151A (es) Analogos de piridazina 1,4-disustituida y metodos para el tratamiento de condiciones relacionadas con la deficiencia de smn.
MX2016001400A (es) Derivados de piridazina 1,4-disustituida, y su uso para el tratamiento de afecciones relacionadas con la deficiencia de smn.
IN2015DN00185A (ar)
MX2015008975A (es) Analogos de tiadiazol y metodos para el tratamiento de afecciones relacionadas con deficiencia del gen de supervivencia de las neuronas motoras (smn).
TN2013000275A1 (en) Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
MX2016000675A (es) Derivados de amino-metil-biarilo como inhibidores del factor de complemento d y usos de los mismos.
MX2015016421A (es) Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades.
SG194463A1 (en) Glycoside derivatives and their uses for the treatment of diabetes
PH12015501752B1 (en) Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
MX2013011926A (es) Derivados de glicosido y usos de los mismos.
MY186598A (en) Carboxamide derivatives
TN2014000060A1 (en) Benzothiazolone compound
MX2016006667A (es) Derivados de pirrolo-pirrolona y su uso como inhibidores.
SA515360076B1 (ar) أملاح من مركب البنزوثيازولون الذي يكون مقاوم لمستقبل أدريني بيتا-2